Retatrutide 30mg

$99.00

See all Sizes
5mg10mg15mg20mg30mg40mg50mg60mg

RESEARCH USE ONLY

10 in stock (can be backordered)

1 Vial
$220.00 Per Vial
$220.00
2 Vials
$209.00 Per Vial (SAVE 5% Per Vial)
$418.00
$440.00
3 Vials
$198.00 Per Vial (SAVE 10% Per Vial)
$594.00
$660.00
4 Vials
$187.00 Per Vial (SAVE 15% Per Vial)
$748.00
$880.00
5 Vials
$176.00 Per Vial (SAVE 20% Per Vial)
$880.00
$1,100.00
6 Vials
$165.00 Per Vial (SAVE 25% Per Vial)
$990.00
$1,320.00
7 Vials
$154.00 Per Vial (SAVE 30% Per Vial)
$1,078.00
$1,540.00
8 Vials
$143.00 Per Vial (SAVE 35% Per Vial)
$1,144.00
$1,760.00
9 Vials
$132.00 Per Vial (SAVE 40% Per Vial)
$1,188.00
$1,980.00
10 Vials
$121.00 Per Vial (SAVE 45% Per Vial)
$1,210.00
$2,200.00
Category:

Description

Retatrutide, also known as LY3437943, is a triple receptor agonist designed to activate GIP, GLP-1, and glucagon receptors.

It has become one of the most closely studied investigational compounds in obesity and metabolic research.

Product Information
Retatrutide combines three metabolic signaling pathways. Clinical trials have demonstrated substantial body-weight reductions and improvements in metabolic measures.

Retatrutide remains an investigational compound rather than an established FDA-approved treatment.

How Does Retatrutide Work?
Retatrutide activates GIP, GLP-1, and glucagon receptors, combining appetite and glucose signaling with metabolic effects associated with glucagon activity.

Retatrutide Benefits & Effects
Promotes Weight Reduction
Clinical trials have demonstrated substantial reductions in body weight with Retatrutide.

Improves Glycemic Control
Clinical research has demonstrated improvements in blood-glucose measures.

Reduces Appetite
GIP and GLP-1 receptor activity influences appetite and satiety signaling.

Supports Metabolic Research
The triple-agonist mechanism makes Retatrutide relevant to obesity, diabetes, liver, and broader metabolic research.

Related products